Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from vari…
| Periodo | 2027-02 |
|---|---|
| Real | — |
| Estimado | — |
| Sorpresa | — |
| Métrica | CTEC.L | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 56.2% | 57.4% | -1.2% |
| Operating Margin | 13.0% | -34.4% | +47.3% |
| Net Margin | 7.2% | -32.5% | +39.6% |
| FCF Margin | — | -12.6% | — |
| ROE | 11.5% | -39.2% | +50.7% |
| ROA | 4.6% | -30.9% | +35.6% |
| Current Ratio | 1.53 | 2.73 | -1.20 |
| Debt / Equity | 0.92 | 0.28 | +0.64 |
| Tendencia (Piotroski) | FY25 | FY24 |
|---|---|---|
| ✓Rentabilidad sobre activos positiva | 4.6% | — |
| ✓Flujo de caja operativo positivo | $470M | $397M |
| ✗Rentabilidad sobre activos al alza | 4.6% | 5.4% |
| ✓Caja operativa/activos supera al ROA | 12.4% | ROA 4.6% |
| ✗Menos deuda a largo plazo | 37.0% | 31.9% |
| ✗Mejor liquidez (ratio corriente) | 1.53 | 1.55 |
| ✗Sin aumentar el nº de acciones | — | — |
| ✓Margen bruto al alza | 56.2% | 56.1% |
| ✗Rotación de activos al alza | 0.65 | 0.65 |
| Calidad del negocio | FY25 |
|---|---|
| ✗ROCE > 10 % | 10.0% |
| ✓Ventas > 5 %/año (3 años) | 5.6% |
| ✓Reinversión (I+D + capex) > 3 % de ventas | 4.6% |
CONVATEC GROUP PLC cotiza a 2.38 GBP y tiene una capitalización bursátil de £4.6B. Datos fundamentales de los informes financieros anuales oficiales (ESEF) vía filings.xbrl.org; cuentas anuales, sin trimestrales.Más empresas del sector Salud